Single-cell elucidation of transcriptional regulatory mechanisms that govern cell surface variation of the human symbiotic bacteria Bacteroidetes
单细胞阐明控制人类共生细菌拟杆菌细胞表面变异的转录调控机制
基本信息
- 批准号:10682388
- 负责人:
- 金额:$ 3.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Antibiotic ResistanceAntibioticsAntibodiesBacteriaBacteriologyBacteriophagesBacteroidesBacteroides fragilisBacteroidetesBar CodesBindingBiochemicalBiochemistryBiological AssayBiological ModelsCell surfaceCellsChIP-seqClostridium difficileCollaborationsComplexCore FacilityCryoelectron MicroscopyDNA-Directed RNA PolymeraseDataDefense MechanismsDevelopmentEngineeringEnvironmentEvolutionFamilyFriendsGene ExpressionGene Expression ProfileGene Expression RegulationGenesGenetic TranscriptionGenomicsGoalsHumanHuman EngineeringImmuneIn VitroInvertaseKnowledgeLearningMentorsMicrobial BiofilmsMicrofluidicsModelingMolecularOperonOutcomePatternPhasePhenotypePolysaccharidesPopulationPopulation HeterogeneityProcessProteinsRegulonReproducibilityResourcesRoentgen RaysSamplingSiteStressStructureSurfaceSystemTechnologyTestingTimeTrainingUniversitiesVariantWorkantibiotic designantiterminationcareercombinatorialcommunity organizationsenvironmental stressorexperienceexperimental studyfollow-upgene expression variationgut microbiotahuman microbiotaimprovedinhibitorinnovationinnovative technologiesmicrofluidic technologypathogenpathogenic bacteriapromoterrational designresistance genesingle cell sequencingsingle cell technologytranscription factor
项目摘要
Project Summary and Abstract
Phase variation of gene expression enables bacteria to generate heterogenous populations and organize
communities that collectively can withstand diverse environmental perturbations. This discrete ON/OFF pattern
of gene expression occurs at multiple loci concurrently to create extensive phenotypic variation, but how
expression from multiple phase variable loci is coordinated is unknown. We developed a breakthrough single-
cell microfluidics technology to study phase variation at multiple loci directly, simultaneously, and over time to
track specialized bacterial sub-populations and learn fundamental principles determining their relative
abundances, rates of development, and interconnectedness. We learn these principles for Bacteroides fragilis,
a crucial human gut symbiote and master of phase variation. B. fragilis directly inhibits pathogens such as
Clostridium difficile and rapidly evolves a vast reservoir of mobile, phase variable antibiotic resistance genes.
Studying phase variation mechanisms in B. fragilis will enhance engineering of human microbiota and rational
design of symbiote-friendly antibiotics to limit evolution and subsequent mobilization of antibiotic-resistance
genes. We combine single-cell microfluidics with genomics and biochemistry to specifically dissect a two-part
regulatory system enabling coordinated phase variation: promoter inversion and termination control. To study
these fundamental principles governing phase variable gene expression, I will be trained primarily in genomics
and single-cell microfluidics by my co-mentors, Dr. Robert Landick and Dr. Ophelia Venturelli. Dr. Landick’s
decades of experience studying fundamental mechanisms of prokaryotic gene regulation combined with Dr.
Venturelli’s expertise in anaerobic bacteriology, engineering, and microfluidics provide me optimal training to
achieve my career goal. The state-of-the-art facilities and resources provided by UW-Madison and the
Departments of Biochemistry and Bacteriology provide me with the optimal environment in which I will carry out
this project.
项目概要和摘要
基因表达的相位变化使细菌能够产生异质群体并组织起来
共同能够承受不同环境扰动的社区。
基因表达的变化同时发生在多个位点以产生广泛的表型变异,但是如何
多相可变基因座的表达是否协调尚不清楚,我们开发了突破性的单相。
细胞微流体技术可直接、同时、随时间研究多个位点的相位变化
跟踪专门的细菌亚群并学习决定其相对关系的基本原理
我们了解脆弱拟杆菌的丰度、发育速度和相互关联性。
脆弱拟杆菌是一种重要的人类肠道共生体,可直接抑制病原体,例如
艰难梭菌迅速进化出大量可移动、相变的抗生素抗性基因。
研究脆弱拟杆菌的相变机制将增强人类微生物群的工程和合理性
设计共生体友好型抗生素,以限制抗生素耐药性的进化和随后的动员
我们将单细胞微流体与基因组学和生物化学相结合,专门剖析两部分。
调节系统可实现协调的相变:启动子反转和终止控制。
这些控制相变基因表达的基本原则,我将主要接受基因组学方面的培训
以及我的合作导师 Robert Landick 博士和 Ophelia Venturelli 博士的单细胞微流体学。
与博士结合数十年研究原核基因调控基本机制的经验。
Venturelli 在厌氧细菌学、工程学和微流体学方面的专业知识为我提供了最佳的培训
实现我的职业目标 威斯康辛大学麦迪逊分校和威斯康星大学麦迪逊分校提供的最先进的设施和资源。
生物化学系和细菌学系为我提供了最佳的环境
这个项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Johnson Jargese Saba其他文献
Johnson Jargese Saba的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Johnson Jargese Saba', 18)}}的其他基金
Single-cell elucidation of transcriptional regulatory mechanisms that govern cell surface variation of the human symbiotic bacteria Bacteroidetes
单细胞阐明控制人类共生细菌拟杆菌细胞表面变异的转录调控机制
- 批准号:
10464643 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别:
相似国自然基金
牛乳中糖肽类抗生素的倏逝波荧光生物传感器快速检测技术研究
- 批准号:31401584
- 批准年份:2014
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
石墨烯增效适配体和抗体夹心双特异性敏感膜识别机理及其应用于抗生素生物传感检测基础研究
- 批准号:31471644
- 批准年份:2014
- 资助金额:90.0 万元
- 项目类别:面上项目
检测环境中抗生素PPCPs的前处理方法学研究
- 批准号:21107104
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
食品中抗生素多残留的磁性纳米金-酶双标记免疫快速检测新技术研究
- 批准号:81072308
- 批准年份:2010
- 资助金额:30.0 万元
- 项目类别:面上项目
以IV型胶原酶的单链抗体与抗肿瘤抗生素力达霉素构建的基因工程融合蛋白(Fv-LDP-AE)抗肿瘤作用机制的研究
- 批准号:30400543
- 批准年份:2004
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
- 批准号:
10678074 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis
非结核分枝杆菌和 B 细胞在异位生发中心刺激和肺结核免疫控制中的作用
- 批准号:
10569865 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Immune recognition of Klebsiella pneumoniae O2v1 and O2v2 O-antigen subtypes
肺炎克雷伯菌 O2v1 和 O2v2 O 抗原亚型的免疫识别
- 批准号:
10739041 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
FimH 靶向抗体招募分子作为预防复杂性尿路感染的新药
- 批准号:
10603693 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别: